Funding Rounds
DiogenX

DiogenX Series A (2023, $30M)

DiogenX

Regenerative diabetes treatment.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $30.15M

Raised Date: 2023-10-01